Designed Delivery - Novel Hydrogels for Drug Delivery from Precisely-Structured Networks

设计的递送 - 用于通过精确结构的网络递送药物的新型水凝胶

• 批准号: DP0987407
• 负责人: Prof Andrew Whittaker
• 金额: $ 29.1万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-06-22 至 2013-03-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP0987407
• 关键词: Designed; Delivery; Novel; Hydrogels; Drug

This project will lead to the development of new biodegradable biomaterials ideally suited to many applications in drug delivery and tissue engineering. The understanding of their properties will be built on comprehensive models for diffusion of molecules through the material. The availability of these new biomaterials will facilitate future developments in drug delivery, and will ultimately lead to improved medical outcomes in many areas such as tissue and bone regeneration. The materials designed in this project will help position the Australian biotechnology and pharmaceutical industries to take advantage of the more than $100B USD market (US alone; growth ~ 10% p.a.) in drug delivery.

该项目将导致新的生物可降解生物材料的发展，非常适合于药物输送和组织工程中的许多应用。对它们的性质的理解将建立在分子通过材料扩散的综合模型上。这些新生物材料的可用性将促进药物递送的未来发展，并最终导致许多领域的医疗结果改善，如组织和骨再生。该项目中设计的材料将有助于澳大利亚生物技术和制药行业利用超过1000亿美元的市场（仅美国;每年增长约10%）。在药物输送方面。